Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Search results for

There are 22,033 results that match your search.22,033 results
  • The China Trade Mark Office (TMO) has recently issued the new Regulations for Recognition and Protection of Well-Known Marks (the Regulations), effective June 1 2003, to replace the 1996 version. The Regulations further clarify the implementation of the Trade Mark Law regarding well-known mark recognition and protection.
  • Optional searching could be the compromise to break the deadlock over the issue of national searches, the head of Europe's trade mark office has suggested.
  • Marion Rees, IP manager, Virax, Australia
  • The registrability of ccTLDs as trade marks burst into the open in Singapore late last year. Though the applications were withdrawn, some legal issues remain outstanding, explains Bryan Tan
  • The Harvard oncomouse drew world attention to the issue of patentability of life forms. Pierre-André Dubois and Kate McCallie explore the divergent approaches of patent authorities in the US, Canada and the EU
  • Improved trade mark legislation and a concentrated effort from rights owners are achieving results against counterfeiting in China. The hope is now the Chinese leadership will take a direct role in the campaign, reports Ralph Cunningham
  • Ralph Cunningham, Hong Kong
  • A local farmer's appeal to Canada's Supreme Court in a case involving agribusiness leader Monsanto could set the limits of patent holders' rights. Sam Mamudi examines the dispute
  • Readers of this column will recall that we published an article last year indicating that the French government was studying a proposed revision of the 'Lois sur la bioéthique'. The draft bill contained an article 12bis, which unambiguously indicated that "the sequence or partial sequence of a gene is not patentable". If adopted, the French law would have been in complete contradiction with the EU Biotechnology Directive (Directive 44/98/CE).
  • The act of using a registered trade mark for the designated goods of that registered trade mark usually constitutes an act of infringement when performed by a third party with no direct rights thereto. Such acts are naturally subject to injunction and damage compensation. However, the case is not so clear-cut in the situation where the third party is importing trade marked goods which are genuine articles manufactured by one having the right to use the trade mark and legitimately purchased in another country (so-called parallel importation). In 1970, the Osaka District Court made it clear that parallel importation of trade marked goods may, in some circumstances, not constitute infringement. Similar decisions have since been issued by other lower courts.